» Articles » PMID: 12556654

The Effect of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure in Patients Treated with Different Antihypertensive Drugs

Overview
Date 2003 Jan 31
PMID 12556654
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertension and arthritis are both common diseases in the older age group and require pharmacologic treatment. Nonsteroidal anti-inflammatory drugs (NSAIDs) alter renal function if given in high enough doses, reducing renal blood flow and the glomerular filtration rate and causing sodium retention. In salt sensitive subjects, this retention of sodium will cause blood pressure to rise. Salt sensitivity is more common in elderly patients, in diabetics, and in people with renal failure. When most antihypertensive drugs are used, people become salt sensitive, as shown by the additive effect of salt restriction or diuretics on blood pressure response. The responses to dihydropyridine and possibly other calcium channel blocking drugs are not affected to any major extent by sodium intake or by diuretics. Studies are described which indicate that indomethacin elevates blood pressure in elderly people treated with enalapril, but not in people whose blood pressure is controlled with amlodipine or felodipine. It is unclear whether the various NSAIDs have different effects on blood pressure. It is proposed that if the same analgesic effect is achieved with the same amount of cyclooxygenase inhibition, the response will be similar. Aspirin, used in a prophylactic dose, does not inhibit to this extent and does not elevate blood pressure. If elderly people require NSAIDs, it would appear that dihydropyridine calcium channel blocking drugs are more effective at lowering and maintaining blood pressure control and should be one of the drugs used. If patients are on other antihypertensive agents, it is important to monitor blood pressure when a NSAID is added to therapy.

Citing Articles

Co-Amorphization, Dissolution, and Stability of Quench-Cooled Drug-Drug Coamorphous Supersaturating Delivery Systems with RT-Unstable Amorphous Components.

Zhang Y, Yao Q, Lin X, Ma Y, Zhang H, Yu H Pharmaceutics. 2025; 16(12.

PMID: 39771470 PMC: 11677066. DOI: 10.3390/pharmaceutics16121488.


Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement.

Faconti L, George J, Partridge S, Maniero C, Sathyanarayanan A, Kulkarni S J Hum Hypertens. 2024; 39(1):1-14.

PMID: 39653728 PMC: 11717708. DOI: 10.1038/s41371-024-00983-6.


Effects of the WHO analgesic ladder on pain severity, pain interference, and blood pressure control in hypertensive patients with chronic musculoskeletal pain: a cross-sectional study.

Srikrajang S, Komolsuradej N, Chaovalit S, Chuaychoosakoon C Prim Health Care Res Dev. 2024; 25:e43.

PMID: 39397485 PMC: 11569861. DOI: 10.1017/S1463423624000367.


Recent updates on the influence of iron and magnesium on vascular, renal, and adipose inflammation and possible consequences for hypertension.

Connolly B, Saxton S J Hypertens. 2024; 42(11):1848-1861.

PMID: 39258532 PMC: 11451934. DOI: 10.1097/HJH.0000000000003829.


Therapeutical Approach to Arterial Hypertension - Current State of the Art.

Radosavljevic M, Vucevic D, Samardzic J, Radenkovic M, Radosavljevic T Curr Med Chem. 2024; 31(29):4602-4620.

PMID: 38303535 DOI: 10.2174/0109298673274823231220063652.


References
1.
Watkins J, Abbott E, Hensby C, Webster J, Dollery C . Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J. 1980; 281(6242):702-5. PMC: 1713997. DOI: 10.1136/bmj.281.6242.702. View

2.
WHELTON A, Schulman G, Wallemark C, Drower E, Isakson P, Verburg K . Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med. 2000; 160(10):1465-70. DOI: 10.1001/archinte.160.10.1465. View

3.
Morgan T, Anderson A, Wilson D, Myers J, Murphy J, Nowson C . Paradoxical effect of sodium restriction on blood pressure in people on slow-channel calcium blocking drugs. Lancet. 1986; 1(8484):793. DOI: 10.1016/s0140-6736(86)91795-2. View

4.
Cinquegrani M, Liang C . Indomethacin attenuates the hypotensive action of hydralazine. Clin Pharmacol Ther. 1986; 39(5):564-70. DOI: 10.1038/clpt.1986.97. View

5.
Patak R, Mookerjee B, Bentzel C, Hysert P, Babej M, Lee J . Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins. 1975; 10(4):649-59. DOI: 10.1016/s0090-6980(75)80012-8. View